6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Press Release Apr 29 2026
4m ago	Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
5m ago	Upstart Announces $1.25B Forward-Flow Agreement with Fortress Investment Group
5m ago	SUNation Energy Ranks No. 1 Solar Installer In PSEG Long Island Territory, With 29% Growth In 2025 Installed Capacity
6m ago	Elektros to Launch "Energy Core" Platform to Shield South Florida Real Estate and Hospitality Assets from Rising Utility Costs

About

Cogent Biosciences Inc (NASDAQ:COGT) — investor relations, events, news, and company updates on 6ix.

Latest News

Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting

Financials

Revenue

$0

Market Cap

$5.75 B

EPS

-2.16

Community Chat

Ask AI